Y 27632

Drug Profile

Y 27632

Latest Information Update: 17 Nov 2009

Price : *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Mitsubishi Pharma Corporation
  • Developer Kyushu University; Medical College of Georgia; Mitsubishi Tanabe Pharma Corporation; Vanderbilt University School of Medicine
  • Class Antiasthmatics; Antihypertensives; Muscle relaxants
  • Mechanism of Action Rho-associated kinase inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No

Highest Development Phases

  • Discontinued Angina pectoris; Asthma; Cardiovascular disorders; Erectile dysfunction; Hypertension

Most Recent Events

  • 17 Nov 2009 Discontinued - Preclinical for Angina pectoris in Japan (unspecified route)
  • 17 Nov 2009 Discontinued - Preclinical for Asthma in USA (unspecified route)
  • 17 Nov 2009 Discontinued - Preclinical for Cardiovascular disorders in Japan (unspecified route)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top